(Q43201853)

16 November 2017

The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man. (English)

1 reference

16 November 2017

1 reference

T C Tham

1

1 reference

16 November 2017

S Guy

2

1 reference

16 November 2017

B J McDermott

3

1 reference

16 November 2017

R G Shanks

4

1 reference

16 November 2017

J G Riddell

5

1 reference

16 November 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

British Journal of Clinical Pharmacology

16 November 2017

1 reference

16 November 2017

40

1 reference

16 November 2017

1

1 reference

16 November 2017

19-23

1 reference

A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man.

16 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365022

The pressor dose-response in clinical cardiovascular pharmacology

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365022

Studies on the mode of vasodilating action of carvedilol

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365022

A new molecule with vasodilating and beta-adrenoceptor blocking properties.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365022

Clinical pharmacology of labetalol

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365022

The assessment of beta-adrenoceptor blocking drugs in man

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365022

Pharmacological basis for antihypertensive effects of intravenous labetalol

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365022

Pharmacological effects of labetalol in man

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365022

The pharmacology of carvedilol

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365022

Analysis of the pressor dose response.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365022

New Tables for Multiple Comparisons with a Control

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1995.TB04529.X

Alpha 1-blocking properties of carvedilol during acute and chronic administration

21 January 2018

1 reference

12 December 2020

Pharmacological profile of carvedilol, a compound with beta-blocking and vasodilating properties

1 reference

12 December 2020

Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol

1 reference

12 December 2020

Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol

1 reference

12 December 2020

Pharmacokinetics and disposition of carvedilol in humans

1 reference

12 December 2020

Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine

1 reference

12 December 2020

10.1111/J.1365-2125.1995.TB04529.X

Identifiers

DOI

1 reference

16 November 2017

1 reference

16 November 2017

PubMed publication ID

8527263

1 reference